I T HAS been shown in experimental animals
that the human fibrinolytic enzyme (plasminogen activated with streptokinase) will dissolve fresh intravascular thrombi. 1 
"
4 Fibrinolytic agents are also undergoing an extensive clinical trial and the preliminary reports which have appeared*" 9 have suggested that this type of therapy will be of value in the management of thrombo-embolic disorders. Variations in the response of patients to therapy have indicated that factors related to the clot, or to the patient's general condition, may alter the lysis of intravascular thrombi.
The experiments to be reported were undertaken to investigate, under controlled conditions, some of the factors which might determine the response to fibrinolytic treatment. It is hoped that the information gained will be of value in the clinical application of fibrinolytic enzymes.
We sought an in vivo test system fulfilling the following 3 requirements. The experimental clot should be composed of the animal's own blood and should not contain foreign substances like bovine thrombin or bovine fibrinogen with their high profibrinolysin content. 10 The clot should be demonstrated and its subsequent fate observed objectively. A relatively fixed end point should be established for complete dissolution.
A modification of the method, reported by Wessler, 11 was found to be satisfactory. With this method, the injection of homologous serum in combination with local vascular stasis leads to the formation of a firm nonadherent clot at the desired site. The formed clot grossly and histologically resembles human phlebothrombosis. For the production of a clot simulating that seen in clinical thromboplebitis, sodium morrhuate was found to be suitable, 11 although this agent induces endothelial damage much more pronounced than that seen even in severe inflammatory thromboplebitis.
Methods
Mongrel dogs, varying in weight from 6.5 to 18 Kg., and maintained on a diet of fresh horse meat, Purina chow and water ad lib were anesthetized with pentobarbital,* 25 mg./Kg., injected intravenously. Serum for clot formation was produced by allowing clotted blood from the experimental dog or a donor dog to stand at room temperature for 30 minutes followed by centifugation at 3,000 EPM for 15 minutes at 10 C.
In pilot experiments, clots were regularly produced by the method originally described by Wessler, but they were frequently not satisfactory because they only partially filled the vessel and were difficult to demonstrate. A modification of the Wessler technic was developed in which a 3 cm. segment of the vessel was isolated between clamps and immediately thereafter 0.15 ml. of serum was injected into the lumen of the vessel through a No. 30 needle (electropolished to reduce vascular damage by the puncture).
•)• The clamps were kept in place for 3 minutes. Large completely occluding clots were formed consistently. A ligature producing 75 per cent occlusion of the vessel lumen was placed prior to removing the clamps, to prevent slippage of the clot. A radiopaque marker was attached to delineate the distal end of the clot.
Sodium morrhuate clots were produced according to a previously reported method.
1 A polyethylene catheter! was inserted through a proximal side branch of the thrombosed vessel for the injection of contrast medium.
In group A, the effect of local and systemic treatment of fresh clots was studied. The effect of
Figure 1
Venograms from control animal: left, immediately after clot formation; middle, 6 hours after formation; and right, 14 hours after formation. local treatment by fibrinolysin was studied by infusing the fibrinolysin* through the catheter. Experiments to compare local and systemic treatments were carried out as follows: Clots were formed simultaneously in 2 vessels on opposite sides and fibrinolysin was infused through the catheter in the side branch on 1 side. This clot was treated locally with a very high concentration of fibrinolysin while the contralateral clot was being treated systemically. In those animals to be treated only systemically, fibrinolysin was infused by a separate intravenous catheter in a distant vessel. Fibrinolysin was infused in doses sufficient to insure a circulating fibrinolytic activity to 10 to 25 minutes (euglobulin method). The range was 4,000 t o13 8,000 Christensen units/Kg./ hour.
Angiograms were performed immediately after clot formation with 4 ml. of contrast media"j" and were repeated before treatment was started to insure the permanency of the clot under controlled conditions. During treatment at intervals of 1 to 2 hours, the angiogram was repeated to determine the status of the clot. "When evidence of complete lysis was found on the angiogram the experiment was discontinued. Three control animals received 5 per cent glucose in water instead of fibrinolysin and angiograms were performed at comparable time intervals. In group B, all operative procedures were carried out under sterile conditions. Serum and morrhuate clots were formed on respective sides exactly as in group A. The wounds were closed, and the animals returned to their cages. At periods ranging from 6 hours to 3 weeks they were re-anesthetized, the thrombosed vessels exposed and a polyethelene catheter was inserted into a proximal side branch. Through this catheter, venograms or arteriograms were performed at 2-hour intervals during the treatment. In these animals, a standard dose of 42,000 units of fibrinolysin per hour for 6 hours was administered through a separate catheter in a femoral vein.
At the termination of the experiments, the vessels were removed and, after fixation in formalin, were sectioned and stained with hemotoxylin and eosin, Masson's trichrome, and phosphotungstic acid. Blood samples were drawn and tested during the course of the experiment to insure the development of a significant circulating fibrinolytic activity by the euglobulin method 12 and by in vitro whole clot lysis. The results of treatment were determined by evaluation of the radiographic and autopsy findings according to the following criteria. X-ray evaluations: 
Results

Group A. Treatment of Fresh Intravascular Clots in Vivo
Twenty-two mongrel dogs were used in this study. Three dogs were used as control animals and 16 were treated with fibrinolysin in the manner described. In an additional 3 dogs, the formation of a clot was studied in the presence of strong fibrinolytic activity.
In the 3 control dogs, the clots remained stable in 2 veins and 2 arteries throughout the course of the experiment ( figs. 1 and 2 ). This has been, confirmed repeatedly in the course of other experiments where the thrombi have persisted for periods beyond 2 weeks.
The effect of treatment with locally administered fibrinolysin was compared with the effect of systemic administration of fibriuolyCirculation Research. Volume VIII, March 1960 sin in 10 animals (table 1). In 6 animals, systemic treatment alone, and in 2 others, local treatment alone was used. In 2 animals, bilateral thrombi were treated as outlined aboA' e with local treatment of 1 and systemic treatment of the other. The local administration of fibrinolysin led to a more rapid and complete dissolution of the clots than did the systemic administration. The average time required for complete clot lysis by local treatment was 2 hours 10 minutes. For systemic treatment, the average time required was 4 hours 45 minutes. In 2 animals (Nos. 8 and 685) the infusion was stopped when the xrays showed evidence of complete lysis. Examination of the veins in these cases revealed small fragments of clot. In 1 animal (No. 7). the venous clot was remarkably resistant to treatment. In spite of the systemic administration of large doses of fibrinolysin for 7 hours, there was no evidence of clot dissolution.
In 5 animals, the effect of systemic fibrinolysin therapy on venous and arterial clots formed simultaneously in the same animal was evaluated (figs. 3 and 4).
Using this technic of clot formation, the clots formed in veins and arteries responded equally well to treatment. Lysis occurred with the same dose and time of treatment (table 2).
The effect of systemic administration of fibrinolysin on venous and arterial clots is summarized in table 3. Using x-ray visualization as a criterion for complete lysis, 17 of the 18 clots were lysed. Using the histologic technic, 13 were completely lysed and 4 showed partial lysis with only small fragments of clot persisting. In only 1 case was there failure to obtain significant lysis.
In the treated series, a marked circulating fibrinolytic and proteolytic activity was noted in 30 minutes to 2 hours after beginning treatment and the activity continued throughout the experiment. The circulating fibrinolytic activity in the course of 1 to 5 hours of treatment ranged from 8 to 25 minutes with an average of 14 minutes. No appreciable difference in the time and effectiveness of in vivo clot lysis was found within this range of fibrinolysin dosage. When marked fibrinolytic activity was encountered in the course of fibrinolysin treatment, heavy oozing of blood from the surgical wounds was observed. No other undesirable side effects were encountered.
The histologic studies performed on vessels and clots in the untreated and in the treated animals revealed that the serum-induced clots were of the mixed variety composed of fibrin, platelets, and numerous red cells in the fibrin meshwork of the clot. In the partially lysed clots which were studied histologically, no structural alterations in the fibrin meshwork were demonstrable. In the vascular wall, a consistent finding was that of slight polymorphonuclear infiltration confined to the adventitia. No difference in the degree of vascular inflammatory reaction was found in the treated compared with the untreated series and no evidence of hemorrhage in any part of the vascular wall was encountered in the treated animals.
Clot Formation in the Fibrinolytic State
In 2 dogs, we had the occasion to study the effect of a spontaneous fibrinolytic state on clot formation. Both dogs received an over-FEEIMAN, BANG, CLIFFTON dose of pentobarbital, resulting in episodes of shock and respiratory arrest. During, and for 10 to 12 hours following the episodes, strong fibrinolytie and proteolytic activity was found in blood samples from both dogs. Bepeated attempts to form clots by the local administration of serum and bovine thrombin were entirely unsuccessful in 1 of these dogs; small clots were formed and demonstrated in the other dog, but were completely dissolved in 4 hours without any treatment. In 1 other dog, a fibrinolytie state was induced by fibrinolysin infusion, prior to attempts at clot formation and repeated local serum injections thereafter did not,result in clot formation.
These studies of in vivo clot formation were supplemented by in vitro studies demonstrating that plasmin added to blood in concentrations of 250 units/ml, immediately after the blood was drawn resulted in complete inhibition of clot formation. Fibriuolysin added to blood in concentrations of 5 to 200 units/ml, resulted in formation of a clot, which, however, dissolved within 1 to 3 minutes. Group B. Fibrinolytie Treatment of Clots of Increasing Age Twenty-oue mongrel dogs were included in part B of the study. Table 4 summarizes the interval between the time of formation ,o£ the clots and the time of treatment in the experimental series and the time of autopsy eyalua- tion in the control series. Angiograms prior to treatment revealed large masses of completely obstructing clot in all the veins examined, and in the control animals they were seen to have undergone organization.
In table 5 , the results of fibrinolysin treatment of 14 dogs at varying time intervals after the formation of clots are shown. It should be noted that in all dogs receiving fibrinolysin up to 4 days after clot formation, evidence of lysis was found. With advancing age, the serum induced clots were more susceptible to fibrinolytic treatment than the sodium morrhuate-induced clots. By the uniform administration of 42,000 units of fibrinolysin per hour for 6 hours, all ger.um clots up to 48
Circulation Research, Volume VIII, March 1960 hours of age were lysed. Only 2 of the morrhuate-induced clots treated within the first 48 hours (6 and 48 hours) showed complete lysis. In the remaining instances, only partial lysis of the morrhuate-induced clots were encountered. In the 4 animals treated on the third and fourth day after the clot formation, the serum clots showed evidence of partial lysis, while 3 morrhuate clots showed partial lysis and the fourth showed uo evidence of lysis. No evidence of therapeutic effect could be demonstrated on clots more than 4 days old. Autopsy examination of clots treated 5 days, or more, after their formation revealed no difference in size and structure compared to the clots of similar age in the control animals. Table 6 summarizes the laboratory data obtained in the 14 treated dogs during the control period and after 4 hours of treatment.
Gross and histologic examination of both the morrhuate-and serum-induced clots in the treated and control animals revealed clots of the white or mixed variety. There was no significant structural differences between the serum and morrhuate clots. In both the control and treated animals, beginning fibroblast invasion with organization and endothelialization was encountered from the fifth day with both the morrhuate and serum clots.
Fibrous tissue was found in appreciable amounts in clots after 8 days. Three clots (one 2 weeks and two 3 weeks of age) were found to be 40 to 50 per cent organized. The 2-weekold serum-induced thrombus was exposed to the standard fibrinolysin treatment for 6 hours. There was no apparent effect noted by radiographic or gross autopsy evaluation. The histologic section revealed complete overgrowth of the clot with vascular endothelium as well as advanced organization.
Prior to the appearance of fibrous tissue and endothelialization at the fifth to eighth day, there were no demonstrable microscopic changes. A fresh clot will lyse rapidly and completely, while a 3-day-old clot shows only partial lysis with the same treatment. This indicates a significant resistance to lysis. However, the histologic appearance of the 2 clots is the same. When a 3-day-clot subjected to fibrinolysin treatment is compared to an untreated 3-day-old clot, there is no significant difference in the structure of the clots.
Although no histologic evidence or organization was encountered in any thrombus less Circulation Research, Volume VIII, March 1960 than 5 days old, a striking change in the physical appearance of the clot was found beginning 24 hours after its formation. At that time, the clot lost the jelly-like consistency characteristic of its fresh state and with advancing age an increasing firmness of the clot was observed long before organization could be demonstrated histologically.
Discussion
The results demonstrate that suitable experimental clots can be produced consistently by the induction of a local hypercoagulable state combined with stasis, and that such clots are susceptible to treatment with human fibrinolysin up to and including the fourth day. The results, as evaluated by x-ray and pathologic examination, indicate a close correlation between these 2 methods. X-ray studies would, therefore, appear to be a reliable method of following the progress of clot dissolution.
In these experiments, fibrinolysin has been administered in large doses in order to produce and maintain a maximum activation of the fibrinolytie enzyme system and a maximum thrombolytic effect in all the treated animals. It is felt that this approach will furnish the most conclusive information about the various factors which may influence the response to fibrinolytie treatment. The marked bleeding tendency observed in these experiments makes it clear that such large doses of fibrinolysin would not be desirable in clinical situations. However, the clinical results reported by Cliffton and other investigators"' 8 ' ° suggest that a good response to therapy can be obtained with lower doses of fibrinolysin by repeated infusions. Our results demonstrate that the instillation of fibrinolysin through a catheter placed in the vicinity of the clot results in a more rapid and complete lysis of the clot than does the systemic administration of this agent through a distant vein. They indicate the dependence of clot lysis upon the constant delivery to the clot of blood with high fibrinolytie activator or enzyme concentration. This again brings up the important question of the role of mechanical factors in the response to fibrinolytie treatment. An ade- 
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quate collateral circulation would appear to be desirable, to insure the adequate delivery of enzyme to the thrombosed area. In subsequent experiments, we demonstrated that clots formed within veins stripped of side branches would dissolve at a slower rate than clots formed in the immediate vicinity of venous tributaries. In the present series, it was also found that fibrinolysin in high doses was equally effective in the treatment of fresh venous and arterial clots. This is in contrast to the clinical and experimental results previously obtained by Cliffton, and Cliffton and Grossi, which seem to indicate that higher doses of fibrinolysin must be administered to affect arterial than venous thrombosis. 5 This difference can be explained by the fact that in their experiments the veins were not stripped of collaterals and the arteries were without collaterals in the area of thrombosis. With the present methods, both veins and arteries are without branches in the region of the thrombus and they therefore act the same.
Our studies of in vivo clot formation revealed that clots could not be formed or maintained for a long time in the presence of circulating fibrinolytie activity. These preliminary observations raise the question of the possible role of fibrinolytie enzymes as prophylactic agents in thrombo-embolic disease.
The results of treatment of clots of increasing age support previously cited studies in establishing approximately the time limit for successful fibrinolvtic treatment. 4 -8 The 14 closely link the increase of the resistance of the clot to the appearance of beginning fibroblast invasion, organization and overgrowth of the thrombus by vascular endothelium. In the present study, however, we have not been able to confirm these results entirely. The results reported here strongly suggest that the resistance of clots to a standard fibrinolytic regimen increases significantly at a time when no histologic evidence of organization is found.
According to one of the prevalent theories 15 of the mechanism of lysis of a thrombus, dissolution of the clot must be preceded by the diffusion of the fibrinolytic enzyme ("activator complex") into the clot where it will function through activation of proenzyme (profibrinolysin) found in large amounts in intimate contact with the fibrin in the clot. It is evident that endothelialization and fibroblast invasion in clots older than 5 days will represent a strong mechanical barrier against the diffusion of either activator complex or active enzyme into the clot. However, the increased resistance of clots which we observe 2 and 3 days after their formation cannot be explained on the basis of such mechanical considerations. There may be a clue however in the observed increase in clot density before fibroblast invasion occurs. At the present time, we can only hypothesize that changes in the fibrin polymer at the molecular level may play a role, either through interference with activation of intrinsic profibrinolysin in the clot, or by altering the diffusion of active enzyme.
The results seem to indicate that with age the serum induced clot is more amenable to fibrinolytic treatment than the morrhuate-induced clot. This observation may have a clinical counterpart in the response of phlebothrombosis and thrombophlebitis to fibrinolytic therapy. Mechanical factors undoubtedly play a role here. The possibilities for delivery of enzyme in adequate concentrations to the entire surface of a thrombus are far better in the case of the soft, nonadherent serum-induced clot than for the firm, adherent morrhuate clot.
The presence of the stenosing ligature necessary to prevent slippage of the clots, led to intense perivascular fibrosis with time and may therefore have induced an artifact by interfering further with the blood flow through the thrombosed area.
The clinical results reported by Cliffton, 5 seem to indicate that a significant effect can be obtained in some cases of peripheral thrombosis treated more than 5 days after the onset of symptoms. In such a comparison between experimental and clinical results, it is important to bear in mind that human clots probably represent a dynamic process with continuous extension of clot and retrograde th rombosis. In some cases, this furtherance of thrombosis may significantly affect collateral circulation. One may therefore be dealing with an original clot which is no longer susceptible to fibrinolytic treatment, but whose recent extensions may still be treated with considerable clinical effect. Summary In 22 dogs, the effect of fibrinolysin therapy of fresh intravascular clots was evaluated by serial angiograms and autopsies. The average time required for dissolution of such clots, when treated by systemic plasmin, was 4 hours and 45 minutes, while the average time necessary for lysis with local fibrinolytic therapy *It can be seen that euglobulin fibrinolytic activity varied between 8 and 23 minutes. A marked drop in fibrinogen concentration to levels as low as 10 mg. per cent was noted. In most instances, a drop in plasmin inhibitor level was encountered, was 2 hours 10 minutes. Treatment of fresh venous and arterial clots did not disclose any significant difference in susceptibility to lysis. In 21 dogs, the effect of age of the clot on the effectiveness of plasmin therapy was studied in elots formed with serum and morrhuate. Clots treated within 4 days of formation were susceptible to dissolution, although clots treated after 3 days did not uniformly undergo complete lysis. The serum-induced clots were more amenable to fibrinolytic therapy than were those formed with morrhuate.
Summario in Interlingua
In 22 canes, le effecto de therapia .a fibrinotysina super fresc coagulos intravascular esseva evalutate per medio de angiogrammas serial e studios necroptic. Le tempore medie requirite pro le dissolution de tal coagulos quando tractate con plasmina systemic esseva 4 horas e 45 minut a s, durante que le tempore medie requirite pro ille lyse post thorapia fibrinolytic local esseva 2 horas e 10 minutas. Le tractamento de frese eoagulos venose e arterial non revelava un differentia significative del snsceptibilitate lytic inter le duo. In 21 canes, le effecto del ctate del coagulo super lo efficacia del therapia a plasniina esseva studiate in coagulos formate per sero o per morrhuato. Coagulos tractate intra 4 dies post lor formation esseva susceptibile de esser dissolvite, ben quo coagulos tractate post plus quo 3 dies non reageva uniformoinento per un lyse complete. Le coagulos inducite per sero esseva plus sensibile al effocto del thorapia fibrinolytic quo le coagulos formate con morrhuato.
